CD44 has been introduced as a cancer stem cells marker in HCC together with CD90, CD133, CD24, and EpCAM, and is reported to be involved in tumor initiation and growth, cancer progression, and promoting metastasis [22,23]. Here, CD44 is linked to hepatocellular carcinoma.